Neutrophil-lymphocyte ratio in Crohn's disease patients predicts sustained response to infliximab 52-week therapy. [electronic resource]

By: Contributor(s): Producer: 20160404Description: 127-8 p. digitalISSN:
  • 1842-1121
Subject(s): In: Journal of gastrointestinal and liver diseases : JGLD vol. 24
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter

There are no comments on this title.

to post a comment.